Friday, January 18, 2013

Developing medicines for rare conditions

Developing new medicines for orphan conditions is indeed a challenge from several perspectives as we have been discussing in the previous articles of this blog. This link will take you to a very recent short article (in English) which gives a historical summary of the orphan drug market and how the pharma industry is moving to this new frontier.

The following articles, while offering more information about the drug development environment, may also give insight in how Advocacy Groups/Foundations/Parents can build up initiatives to make new medicines available

Beaulieu CL et al. Orphanet Journal of Rare Diseases 2012;7:39.
Frangioni JVNature Biotechnology 2012;30:928–32.
Dolgin ENature Medicine 2012;18:335.

All of them are free access.

No comments:

Post a Comment